Olaparib 150mg Tablet for BRCA-Mutated Ovarian, Breast & Pancreatic Cancer

Brcaone 150mg Tablet contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of BRCA-mutated ovarian cancer and HER2-negative breast cancer, and in certain pancreatic and prostate cancers. It works by blocking the PARP enzyme that cancer cells rely on to repair damaged DNA, causing cancer cells carrying a BRCA mutation to die while sparing most healthy cells. Manufactured by Emcure Pharmaceuticals Ltd, this is a prescription-only oncology medicine to be used strictly under an oncologist’s supervision.

Key Features

• Targeted DNA-Repair Blockade – inhibits PARP enzymes that cancer cells need to repair damaged DNA
• BRCA-Mutation Focused – used in ovarian, breast, pancreatic and prostate cancers linked to BRCA1/BRCA2 mutations
• Maintenance & Treatment Therapy – used alone or following chemotherapy response to delay disease progression
• Twice-Daily Oral Dosing – 150mg tablet taken with or without food, morning and evening
• Prescription-Only Oncology Medicine – dispensed and used strictly under an oncologist’s care

Key Ingredients

• Olaparib (150mg)
• Film-coating & pharmaceutical excipients q.s.

Uses & Benefits

• Treatment of BRCA-mutated ovarian cancer, including maintenance therapy after chemotherapy response
• Treatment of HER2-negative, BRCA-mutated breast cancer
• May be used in certain BRCA-mutated pancreatic and prostate cancers
• Helps slow tumour growth and delay disease progression as part of a prescribed regimen

Directions for Use

• Take exactly as prescribed by your oncologist, usually twice daily
• Swallow tablets whole; do not chew, crush, or split them
• May be taken with or without food, at the same times each day
• If a dose is missed, skip it and continue with the next scheduled dose – do not double up

Precautions

• Rx Only: a high-strength oncology medicine to be dispensed and used strictly under ongoing specialist supervision
• Regular blood counts are required to monitor for anaemia and low white blood cell counts
• Highly unsafe in pregnancy – effective contraception is required for both partners during treatment and for a period after stopping
• Avoid grapefruit and grapefruit juice, which can increase the risk of side effects
• Use with caution in significant liver or kidney impairment – your doctor may need to adjust the dose
• May cause fatigue or dizziness – avoid driving or operating machinery until you know how it affects you

Storage

• Store below 30°C, protected from light and moisture
• Keep out of reach and sight of children
• Keep in the original pack until use

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. PMC Herbals sells this product strictly against a valid prescription.

The post Brcaone 150mg Tablet appeared first on PMC Herbals.

Olaparib 150mg Tablet for BRCA-Mutated Ovarian, Breast & Pancreatic Cancer

Olabir Tablet contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of BRCA-mutated ovarian cancer and HER2-negative breast cancer, and in certain pancreatic and prostate cancers. It works by blocking the PARP enzyme that cancer cells rely on to repair damaged DNA, causing cancer cells carrying a BRCA mutation to die while sparing most healthy cells. Manufactured by Aprazer Healthcare Pvt Ltd, this is a prescription-only oncology medicine to be used strictly under an oncologist’s supervision.

Key Features

• Targeted DNA-Repair Blockade – inhibits PARP enzymes that cancer cells need to repair damaged DNA
• BRCA-Mutation Focused – used in ovarian, breast, pancreatic and prostate cancers linked to BRCA1/BRCA2 mutations
• Maintenance & Treatment Therapy – used alone or following chemotherapy response to delay disease progression
• Twice-Daily Oral Dosing – 150mg tablet taken with or without food, morning and evening
• Prescription-Only Oncology Medicine – dispensed and used strictly under an oncologist’s care

Key Ingredients

• Olaparib (150mg)
• Film-coating & pharmaceutical excipients q.s.

Uses & Benefits

• Treatment of BRCA-mutated ovarian cancer, including maintenance therapy after chemotherapy response
• Treatment of HER2-negative, BRCA-mutated breast cancer
• May be used in certain BRCA-mutated pancreatic and prostate cancers
• Helps slow tumour growth and delay disease progression as part of a prescribed regimen

Directions for Use

• Take exactly as prescribed by your oncologist, usually twice daily
• Swallow tablets whole; do not chew, crush, or split them
• May be taken with or without food, at the same times each day
• If a dose is missed, skip it and continue with the next scheduled dose – do not double up

Precautions

• Rx Only: a high-strength oncology medicine to be dispensed and used strictly under ongoing specialist supervision
• Regular blood counts are required to monitor for anaemia and low white blood cell counts
• Highly unsafe in pregnancy – effective contraception is required for both partners during treatment and for a period after stopping
• Avoid grapefruit and grapefruit juice, which can increase the risk of side effects
• Use with caution in significant liver or kidney impairment – your doctor may need to adjust the dose
• May cause fatigue or dizziness – avoid driving or operating machinery until you know how it affects you

Storage

• Store below 30°C, protected from light and moisture
• Keep out of reach and sight of children
• Keep in the original pack until use

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. PMC Herbals sells this product strictly against a valid prescription.

The post Olabir Tablet appeared first on PMC Herbals.

Olaparib 150mg Tablet for BRCA-Mutated Ovarian, Breast & Pancreatic Cancer

Lynparza 150mg Tablet contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of BRCA-mutated ovarian cancer and HER2-negative breast cancer, and in certain pancreatic and prostate cancers. It works by blocking the PARP enzyme that cancer cells rely on to repair damaged DNA, causing cancer cells carrying a BRCA mutation to die while sparing most healthy cells. Manufactured by AstraZeneca, this is a prescription-only oncology medicine to be used strictly under an oncologist’s supervision.

Key Features

• Targeted DNA-Repair Blockade – inhibits PARP enzymes that cancer cells need to repair damaged DNA
• BRCA-Mutation Focused – used in ovarian, breast, pancreatic and prostate cancers linked to BRCA1/BRCA2 mutations
• Maintenance & Treatment Therapy – used alone or following chemotherapy response to delay disease progression
• Twice-Daily Oral Dosing – 150mg tablet taken with or without food, morning and evening
• Prescription-Only Oncology Medicine – dispensed and used strictly under an oncologist’s care

Key Ingredients

• Olaparib (150mg)
• Film-coating & pharmaceutical excipients q.s.

Uses & Benefits

• Treatment of BRCA-mutated ovarian cancer, including maintenance therapy after chemotherapy response
• Treatment of HER2-negative, BRCA-mutated breast cancer
• May be used in certain BRCA-mutated pancreatic and prostate cancers
• Helps slow tumour growth and delay disease progression as part of a prescribed regimen

Directions for Use

• Take exactly as prescribed by your oncologist, usually twice daily
• Swallow tablets whole; do not chew, crush, or split them
• May be taken with or without food, at the same times each day
• If a dose is missed, skip it and continue with the next scheduled dose – do not double up

Precautions

• Rx Only: a high-strength oncology medicine to be dispensed and used strictly under ongoing specialist supervision
• Regular blood counts are required to monitor for anaemia and low white blood cell counts
• Highly unsafe in pregnancy – effective contraception is required for both partners during treatment and for a period after stopping
• Avoid grapefruit and grapefruit juice, which can increase the risk of side effects
• Use with caution in significant liver or kidney impairment – your doctor may need to adjust the dose
• May cause fatigue or dizziness – avoid driving or operating machinery until you know how it affects you

Storage

• Store below 30°C, protected from light and moisture
• Keep out of reach and sight of children
• Keep in the original pack until use

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. PMC Herbals sells this product strictly against a valid prescription.

The post Lynparza 150mg Tablet appeared first on PMC Herbals.

Olaparib 150mg Tablet for BRCA-Mutated Ovarian, Breast & Pancreatic Cancer

Olabir 150mg Tablet contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of BRCA-mutated ovarian cancer and HER2-negative breast cancer, and in certain pancreatic and prostate cancers. It works by blocking the PARP enzyme that cancer cells rely on to repair damaged DNA, causing cancer cells carrying a BRCA mutation to die while sparing most healthy cells. Manufactured by Aprazer Healthcare Pvt Ltd, this is a prescription-only oncology medicine to be used strictly under an oncologist’s supervision.

Key Features

• Targeted DNA-Repair Blockade – inhibits PARP enzymes that cancer cells need to repair damaged DNA
• BRCA-Mutation Focused – used in ovarian, breast, pancreatic and prostate cancers linked to BRCA1/BRCA2 mutations
• Maintenance & Treatment Therapy – used alone or following chemotherapy response to delay disease progression
• Twice-Daily Oral Dosing – 150mg tablet taken with or without food, morning and evening
• Prescription-Only Oncology Medicine – dispensed and used strictly under an oncologist’s care

Key Ingredients

• Olaparib (150mg)
• Film-coating & pharmaceutical excipients q.s.

Uses & Benefits

• Treatment of BRCA-mutated ovarian cancer, including maintenance therapy after chemotherapy response
• Treatment of HER2-negative, BRCA-mutated breast cancer
• May be used in certain BRCA-mutated pancreatic and prostate cancers
• Helps slow tumour growth and delay disease progression as part of a prescribed regimen

Directions for Use

• Take exactly as prescribed by your oncologist, usually twice daily
• Swallow tablets whole; do not chew, crush, or split them
• May be taken with or without food, at the same times each day
• If a dose is missed, skip it and continue with the next scheduled dose – do not double up

Precautions

• Rx Only: a high-strength oncology medicine to be dispensed and used strictly under ongoing specialist supervision
• Regular blood counts are required to monitor for anaemia and low white blood cell counts
• Highly unsafe in pregnancy – effective contraception is required for both partners during treatment and for a period after stopping
• Avoid grapefruit and grapefruit juice, which can increase the risk of side effects
• Use with caution in significant liver or kidney impairment – your doctor may need to adjust the dose
• May cause fatigue or dizziness – avoid driving or operating machinery until you know how it affects you

Storage

• Store below 30°C, protected from light and moisture
• Keep out of reach and sight of children
• Keep in the original pack until use

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. PMC Herbals sells this product strictly against a valid prescription.

The post Olabir 150mg Tablet appeared first on PMC Herbals.

Olaparib 150mg Tablet for BRCA-Mutated Ovarian, Breast & Pancreatic Cancer

Obparp 150 Tablet contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of BRCA-mutated ovarian cancer and HER2-negative breast cancer, and in certain pancreatic and prostate cancers. It works by blocking the PARP enzyme that cancer cells rely on to repair damaged DNA, causing cancer cells carrying a BRCA mutation to die while sparing most healthy cells. Manufactured by Cipla Ltd, this is a prescription-only oncology medicine to be used strictly under an oncologist’s supervision.

Key Features

• Targeted DNA-Repair Blockade – inhibits PARP enzymes that cancer cells need to repair damaged DNA
• BRCA-Mutation Focused – used in ovarian, breast, pancreatic and prostate cancers linked to BRCA1/BRCA2 mutations
• Maintenance & Treatment Therapy – used alone or following chemotherapy response to delay disease progression
• Twice-Daily Oral Dosing – 150mg tablet taken with or without food, morning and evening
• Prescription-Only Oncology Medicine – dispensed and used strictly under an oncologist’s care

Key Ingredients

• Olaparib (150mg)
• Film-coating & pharmaceutical excipients q.s.

Uses & Benefits

• Treatment of BRCA-mutated ovarian cancer, including maintenance therapy after chemotherapy response
• Treatment of HER2-negative, BRCA-mutated breast cancer
• May be used in certain BRCA-mutated pancreatic and prostate cancers
• Helps slow tumour growth and delay disease progression as part of a prescribed regimen

Directions for Use

• Take exactly as prescribed by your oncologist, usually twice daily
• Swallow tablets whole; do not chew, crush, or split them
• May be taken with or without food, at the same times each day
• If a dose is missed, skip it and continue with the next scheduled dose – do not double up

Precautions

• Rx Only: a high-strength oncology medicine to be dispensed and used strictly under ongoing specialist supervision
• Regular blood counts are required to monitor for anaemia and low white blood cell counts
• Highly unsafe in pregnancy – effective contraception is required for both partners during treatment and for a period after stopping
• Avoid grapefruit and grapefruit juice, which can increase the risk of side effects
• Use with caution in significant liver or kidney impairment – your doctor may need to adjust the dose
• May cause fatigue or dizziness – avoid driving or operating machinery until you know how it affects you

Storage

• Store below 30°C, protected from light and moisture
• Keep out of reach and sight of children
• Keep in the original pack until use

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. PMC Herbals sells this product strictly against a valid prescription.

The post Obparp 150 Tablet appeared first on PMC Herbals.

Lynparza 100mg Tablet is a targeted anti-cancer prescription medicine containing Olaparib 100mg, manufactured by AstraZeneca. It is a PARP inhibitor used in the treatment of ovarian and breast cancer, blocking an enzyme that helps cancer cells repair damaged DNA so that tumour cells die off and growth slows.

Key Features

• Contains Olaparib 100mg, a targeted PARP inhibitor
• Used in the treatment of ovarian and breast cancer
• Offers a maintenance therapy option that can delay further chemotherapy
• Manufactured by AstraZeneca
• Prescription-only (Rx) oncology medicine, strip of 8 film-coated tablets

Composition

• Olaparib – 100mg

Uses & Benefits

• Treatment of ovarian cancer, including newly diagnosed and recurrent cases
• Treatment of breast cancer as part of a targeted therapy regimen
• Specifically inhibits PARP in cancer cells while sparing most healthy cells
• Can help slow disease progression and improve overall outcomes

Directions for Use

• Take strictly in the dose and duration advised by your oncologist
• Swallow the tablet whole; do not chew, crush or split it
• May be taken with or without food, at the same time each day
• Do not stop or alter the dose without consulting your doctor

Precautions

• To be sold strictly on the prescription of a Registered Medical Practitioner
• Avoid grapefruit or grapefruit juice during treatment
• Regular blood tests are needed to monitor blood cell counts and liver function
• Common side effects include nausea, vomiting, fatigue and anaemia
• Can harm an unborn baby – use effective contraception during and after treatment
• Not recommended during pregnancy or breastfeeding
• Do not start new medicines or supplements without consulting your doctor

Storage

• Store as per label directions in a cool, dry place away from direct sunlight
• Keep out of reach and sight of children

Disclaimer: This is a high-cost, prescription-only oncology medicine. The information provided is for general awareness only and does not substitute professional medical advice. Please consult a Registered Medical Practitioner/oncologist before use.

The post Lynparza 100mg Tablet appeared first on PMC Herbals.